1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. RENEO PHARMACEUTICALS INC

Reneo Pharmaceuticals Inc

XNAS: RPHM

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Reneo Pharmaceuticals Inc is on 28 Mar 2025 for the purpose of Reneo Pharmaceuticals Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Reneo Pharmaceuticals Inc

The latest disclosure was made by Ashley Hall in Reneo Pharmaceuticals Inc where a trade of 15,625 Common Stock done at an average price of $1.8 was reported to US exchanges on Aug. 28, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Ashley Hall Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.80 per share. 28 Aug 2023 15,625 55,225 - 1.8 28,125 Common Stock
Ashley Hall Chief Development Officer Sale of securities on an exchange or to another person at price $ 6.28 per share. 28 Aug 2023 15,625 39,600 - 6.3 98,058 Common Stock
Ashley Hall Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Aug 2023 15,625 109,375 - - Stock option (right to buy)
Roshawn A. Blunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 14,815 14,815 - - Stock Option (right to buy)
Bali Muralidhar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 17,500 17,500 - - Stock Option (right to buy)
Niall O’Donnell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 17,500 17,500 - - Stock Option (right to buy)
Eric M. Dube Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 17,500 17,500 - - Stock Option (right to buy)
Stacey D. Seltzer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 17,500 17,500 - - Stock Option (right to buy)
Paul W. Hoelscher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 17,500 17,500 - - Stock Option (right to buy)
Edward T. Mathers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 17,500 17,500 - - Stock Option (right to buy)
Niall O’Donnell Director Purchase of securities on an exchange or from another person at price $ 8.00 per share. 08 May 2023 125,000 2,188,713 - 8 1,000,000 Common Stock
Ashley Hall Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2022 125,000 125,000 - - Stock option (right to buy)
Alejandro Dorenbaum Chief Medical Officer Gift of securities by or to the insider at price $ 0.00 per share. 09 Dec 2022 22,348 30,000 - 0 Common Stock
Alejandro Dorenbaum Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2022 125,000 125,000 - - Stock option (right to buy)
Michael Cruse Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2022 125,000 125,000 - - Stock option (right to buy)
Jennifer P. Lam VP of Finance & Administration Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2022 90,000 90,000 - - Stock option (right to buy)
Michael Cruse Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 3.39 per share. 01 Sep 2022 7,500 13,697 - 3.4 25,448 Common Stock
Michael Cruse Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 3.21 per share. 29 Aug 2022 3,212 6,197 - 3.2 10,307 Common Stock
Michael Cruse Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 3.19 per share. 29 Aug 2022 1,845 2,985 - 3.2 5,893 Common Stock
Michael Cruse Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 3.24 per share. 29 Aug 2022 1,140 1,140 - 3.2 3,694 Common Stock
Michael Cruse Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 3.24 per share. 29 Aug 2022 83 30,783 - 3.2 269 Common Stock
Michael Cruse Chief Operating Officer Purchase of securities on an exchange or from another person at price $ 3.16 per share. 29 Aug 2022 975 31,758 - 3.2 3,081 Common Stock
Roshawn A. Blunt Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Aug 2022 35,000 35,000 - - Stock Option (right to buy)
Stacey D. Seltzer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 17,500 17,500 - - Stock Option (right to buy)
Paul W. Hoelscher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 6,376 6,376 - - Stock Option (right to buy)
Edward T. Mathers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 17,500 17,500 - - Stock Option (right to buy)
Eric Dube Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 17,500 17,500 - - Stock Option (right to buy)
Niall O’Donnell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 17,500 17,500 - - Stock Option (right to buy)
Bali Muralidhar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jun 2022 17,500 17,500 - - Stock Option (right to buy)
Paul W. Hoelscher Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2022 35,000 35,000 - - Stock Option (right to buy)
Vineet Jindal Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2021 100,000 100,000 - - Stock option (right to buy)
Vineet Jindal Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2021 30,000 36,600 - 0 Common Stock
Alejandro Dorenbaum Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2021 30,000 52,348 - 0 Common Stock
Alejandro Dorenbaum Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2021 100,000 100,000 - - Stock option (right to buy)
Michael Cruse Senior VP-Corporate Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2021 75,000 75,000 - - Stock option (right to buy)
Michael Cruse Senior VP-Corporate Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2021 25,000 29,100 - 0 Common Stock
Ashley Hall Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 180,000 180,000 - - Stock Option (right to buy)
Ashley Hall Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Nov 2021 30,000 30,000 - 0 Common Stock
Michael Cruse Senior VP-Corporate Operations Purchase of securities on an exchange or from another person at price $ 7.45 per share. 25 Aug 2021 2,500 2,500 - 7.4 18,616 Common Stock
Vineet Jindal Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 7.44 per share. 25 Aug 2021 5,000 5,000 - 7.4 37,177 Common Stock
Wendy S. Johnson Chief Development Officer Sale of securities on an exchange or to another person at price $ 8.50 per share. 14 Jul 2021 111,736 0 - 8.5 949,756 Common Stock
Bali Muralidhar Director Purchase of securities on an exchange or from another person at price $ 8.50 per share. 14 Jul 2021 111,736 2,073,957 - 8.5 949,756 Common Stock
Wendy S. Johnson Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.97 per share. 08 Jul 2021 111,736 111,736 - 2.0 220,120 Common Stock
Wendy S. Johnson Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 08 Jul 2021 111,736 0 - - Stock option (right to buy)
Bali Muralidhar Director Purchase of securities on an exchange or from another person at price $ 9.28 per share. 23 Jun 2021 20,710 1,962,221 - 9.3 192,245 Common Stock
Bali Muralidhar Director Purchase of securities on an exchange or from another person at price $ 8.72 per share. 21 Jun 2021 14,615 1,941,511 - 8.7 127,487 Common Stock
Bali Muralidhar Director Purchase of securities on an exchange or from another person at price $ 9.03 per share. 21 Jun 2021 32,659 1,926,896 - 9.0 294,927 Common Stock
Bali Muralidhar Director Purchase of securities on an exchange or from another person at price $ 9.50 per share. 08 Jun 2021 16,605 1,894,237 - 9.5 157,709 Common Stock
Bali Muralidhar Director Purchase of securities on an exchange or from another person at price $ 9.42 per share. 03 Jun 2021 257 1,877,632 - 9.4 2,422 Common Stock
Bali Muralidhar Director Purchase of securities on an exchange or from another person at price $ 9.25 per share. 03 Jun 2021 12,100 1,877,375 - 9.3 111,943 Common Stock
Bali Muralidhar Director Purchase of securities on an exchange or from another person at price $ 9.50 per share. 28 May 2021 14 1,865,275 - 9.5 133 Common Stock
Bali Muralidhar Director Purchase of securities on an exchange or from another person at price $ 9.26 per share. 26 May 2021 1,120 1,865,261 - 9.3 10,369 Common Stock
Bali Muralidhar Director Purchase of securities on an exchange or from another person at price $ 9.38 per share. 26 May 2021 5,915 1,864,141 - 9.4 55,495 Common Stock
Niall O’Donnell Director 13 Apr 2021 3,710,116 0 - - Series B Preferred Stock
Bali Muralidhar Director 13 Apr 2021 7,420,232 0 - - Series B Preferred Stock
Bali Muralidhar Director Purchase of securities on an exchange or from another person at price $ 15.00 per share. 13 Apr 2021 200,000 1,858,226 - 15 3,000,000 Common Stock
Bali Muralidhar Director 13 Apr 2021 1,658,226 1,658,226 - - Common Stock
Niall O’Donnell Director 13 Apr 2021 1,034,600 1,034,600 - - Common Stock
Niall O’Donnell Director 13 Apr 2021 4,629,630 0 - - Series A Preferred Stock
Niall O’Donnell Director Purchase of securities on an exchange or from another person at price $ 15.00 per share. 13 Apr 2021 200,000 2,063,713 - 15 3,000,000 Common Stock
Niall O’Donnell Director 13 Apr 2021 829,113 1,863,713 - - Common Stock
Edward T. Mathers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 14,000 14,000 - - Stock Option (right to buy)
Lon Cardon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 14,000 14,000 - - Stock Option (right to buy)
Bali Muralidhar Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 14,000 14,000 - - Stock Option (right to buy)
Niall O’Donnell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 14,000 14,000 - - Stock Option (right to buy)
Stacey D. Seltzer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Apr 2021 14,000 14,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters